Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proliposome-based transdermal delivery of levonorgestrel

M R Deo1, V P Sant, S R Parekh

  • 1Bharati Vidyapeeth's Poona College of Pharmacy, Erandwane Pune, India.

Journal of Biomaterials Applications
|July 1, 1997
PubMed
Summary

This study developed a novel proliposomal system for transdermal levonorgestrel delivery. The system showed promising results for effective drug delivery, outperforming conventional ointments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of mesophasic microreservoir-based transdermal drug delivery system of propranolol.

Indian journal of pharmaceutical sciences·2011
Same author

Development of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer.

International journal of pharmaceutics·2002
Same author

Dendrimer grafts for delivery of 5-fluorouracil.

Die Pharmazie·2002
Same author

Azo-containing urethane analogues for colonic drug delivery: synthesis, characterization and in-vitro evaluation.

The Journal of pharmacy and pharmacology·2001
Same author

Enhancement of anti-metastatic activity of pentoxifylline by encapsulation in conventional liposomes and sterically stabilized liposomes in murine experimental B16F10 melanoma model.

The Journal of pharmacy and pharmacology·2001
Same author

High-entrapment liposomes for 6-Mercaptopurine--a prodrug approach.

Drug development and industrial pharmacy·2001

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Dermatology

Background:

  • Transdermal drug delivery offers a non-invasive route for systemic drug administration.
  • Levonorgestrel, a hydrophobic drug, presents challenges for effective transdermal delivery.
  • Proliposomal systems are investigated as advanced formulations for enhanced drug permeation.

Purpose of the Study:

  • To develop and evaluate a mesophasic proliposomal system for transdermal levonorgestrel delivery.
  • To investigate the in vitro and in vivo performance of the developed proliposomal system.
  • To compare the efficacy of the proliposomal system with a conventional polyethylene glycol (PEG)-based ointment.

Main Methods:

  • Formulation of a mesophasic proliposomal system containing levonorgestrel.

Related Experiment Videos

  • In vitro characterization of vesicle morphology (unilamellar/multilamellar) and drug release kinetics (zero order).
  • In vivo evaluation in animal models to assess transdermal flux, lag phase, and therapeutic levels, with comparison to a PEG-based ointment control.

    • Main Results:

    • The proliposomal system exhibited mostly unilamellar vesicles with spontaneous budding upon hydration.
    • Drug release followed zero-order kinetics, indicating sustained release.
    • Transdermal flux was highest with alcohols, followed by lemon oil. In vivo studies revealed a lag phase, necessitating a loading dose.
    • The proliposomal system demonstrated superior performance compared to the PEG-based ointment.

    Conclusions:

    • The developed mesophasic proliposomal system is a viable and efficacious platform for transdermal delivery of hydrophobic drugs like levonorgestrel.
    • The system offers advantages over conventional topical formulations, suggesting potential for improved therapeutic outcomes.
    • Further optimization, including loading dose strategies, may enhance clinical applicability.